ICYMI: FDA Approves HIV Prevention Drug That Isn't Safety Tested for All
The Food and Drug Administration says that safety trials for Descovy primarily tested White cisgender men.
ICYMI: HIV Prevention Drug PrEP to Be Covered by Most Insurance Plans
At $2,000 per month, the pill is currently inaccessible to most of the people who are at highest risk of contracting HIV.
The Best Medication to Prevent HIV is Hard to Find Where It's Needed Most
The dangerously scarce availability of PrEP is contributing to high HIV infection rates in Black men.